Open access
Mahanimbine as an AKT1 Modulator in Breast Cancer: Mechanisms and Therapeutic Potential
Abstract
<jats:p>.</jats:p>
Similar papers
Editorial
Aug 2026
Targeting Enzymes for Cancer Therapy: Attractive Targets and Therapeutic Strategies.
<jats:sec> <jats:title/> <jats:p/> </jats:sec>
Guang Huang
· Anti-Cancer Agents in Medici... · 0 citations
Open access
2026
Senescence-associated secretory phenotype in urological cancers: molecular mechanisms, tumor microenvironment modulation, and therapeutic targeting
,
Yan-Le Zhu, Wen-Hao Zhang, Yun-Qiu Gao
· European Cytokine Network · 0 citations
HDAC Inhibition by Trichostatin A in U266 Multiple Myeloma: Anti-Proliferative Effects, Transcriptomic Dysregulation, Core Gene Clusters, and Survival-Associated Biomarkers
Ismail NH Ab, Mohamed Yusoff, MF Johan et al.
· 0 citations
Open access
Sep 2026
Combined talimogene laherparepvec and binimetinib in NRAS-mutated melanoma induces anti-tumor immunity.
<jats:p/>
Tony Yao, Rita E. Chen, Melissa M. Yamada et al.
· Journal of Clinical Investig... · 0 citations
Open access
Sep 2026
Correction to: Photobiomodulation therapy moderates cancer cachexia‑associated muscle wasting through activating PI3K/AKT/FoxO3a pathway
Yong-Hua Li, Yi-Bing Chen, Yuan Liao et al.
· Apoptosis · 0 citations
Open access
Sep 2026
Natural Coumarins as ABC Transporters Modulators: A Key Mechanistic Question for Osteosarcoma Chemotherapy
the
Shi-Hong Ren
· Chemistry and Biodiversity · 0 citations